20Med Therapeutics Appoints Industry Veteran Hugo Fry as
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo...
Source: globenewswire.com
📰 Valency Communications News
Valency Communications News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Valency Communications. Real-time updates on events, politics, business and more.
Mendus will participate in multiple investor and industry conferences in October and announces presentation of ALISON trial update at SITC
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: LSX...
Source: marketscreener.com
Mendus to present novel data supporting the broad potential of its proprietary cancer vaccine platform at CICON23
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will present novel clinical and preclinical data on the mode of action of its lead clinical program...
Source: marketscreener.com
Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia (AML)
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that it has received Fast Track Designation from the U.S. Food and Drug Administration ...
United States Corey Davis Mario Brkulj Erik Manting American Society Of Hematology Valency Communications
Source: marketscreener.com
Mendus Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference in September
Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company will present a company presentation and participate in one-on-one...
Source: marketscreener.com
Mendus to participate in multiple investor and industry conferences in September
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: H.C. Wainwright 25th Annual Global Investment Conference New York, USA, September 11-13, 2023 Mendus CEO Erik Manting will participate and present a Company Update at the conference: https://hcwevents.com/annualconference/ Pareto Securities' Annual Healthcare Confer...
Source: yahoo.com
Change in number of shares and votes in Mendus AB (publ)
As previously announced Mendus AB has carried out a capital raise whereby 472,953,859 new shares were issued in a rights issue and 187,500,000 new shares were issued in a directed issue. As a...
Erik Manting Corey Davis Mario Brkulj Valency Communications Lifesci Advisors Swedish Financial Instruments Trading Act
Source: marketscreener.com
Mendus receives ATMP certificate from European Medicines Agency supporting its lead pipeline program vididencel
POSITIVE RECOMMENDATION BY COMMITTEE FOR ADVANCED THERAPIES CONFIRMS QUALITY OF THE MANUFACTURING PROCESS AND PRECLINICAL DATA SUBMITTED Mendus AB , a biopharmaceutical company focused on... | June 19, 2023
Erik Manting Mario Brkulj Leopold Bertea Corey Davis European Medicines Agency Valency Communications
Source: marketscreener.com
Mendus AB: Mendus announces a directed share issue and a fully secured rights issue of units totaling approximately SEK 317 million in financing
08.06.2023 - THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, ...
Source: wallstreet-online.de
Mendus AB: Notice of Extraordinary General Meeting in
The shareholders of Mendus AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting (“EGM”) on Monday, 10...
Corey Davis Mario Brkulj Erik Manting European Parliament Swedish Companies Swedish Companies Registration Office
Source: globenewswire.com